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Conclusions: Reanastomosis of the divided left renal
vein undergoing AAA repair does not provide any long-
term advantage over ligation in patients with either normal
or slightly abnormal preoperative renal function.
Comparison of patient characteristics between groups.
RLRV (n10) LLRV (n14) P-value
Age (Mean  SD) 70  4.0 69.5  10.9 ns
Gender (% male) 80% (8) 85.7% (12) ns
DM 10% (1) 14.4% (2) ns
HTN 60% (6) 64.4% (9) ns
CAD 40% (4) 57.1% (8) ns
Nicotine Abuse 100% (10) 92.9% (13) ns
Diameter of Aneurysm 7.0  1.8 6.8  1.3 ns
Preoperative Creatinine 1.3  0.47 1.2  0.36 ns
Creatinine Clearance 66.1  19.8 82.8  40.1 ns
Site of Cross-Clamping
Interrenal 70% (7) 33.3% (4)
Suprarenal 30% (3) 66.7% (10)
Changes in creatinine clearance over time.
Categories
Preoperative
creatinine
clearance (ml)
Postoperative
creatinine clearance
(ml)—day 7
Latest creatinine
clearance (mean
48  4 months/mL)
RLRV 66.1  19.8 41.9  27.0 47.1  20.2
LLRV 82.8  40.1 73.9  37.9 61.9  38.9
P-value  ns
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Objectives: The CardioMEMS EndoSure wireless
pressure sensor has been used to ensure exclusion of the
aortic sac during endovascular aortic repair (EVAR). How-
ever, little has been studied regarding the impact of the
pressure sensor on longitudinal axial imaging studies.
Methods: 79 patients underwent EVAR with implanta-
tion of the EndoSure device. All patients had post exclusion
sensor readings taken at the time of operation. All follow-up
visits were accompanied by EndoSure sensor reading and CT
scan. A total of 205 readings were matched with concurrent
CT scan for evaluation of aortic sac size and presence of
endoleak. Exclusion of the sacwas defined by a reduction of at
least 30% in either systolic or pulse pressure. Patients whose
sensor readings signaled non-exclusion were analyzed by uni-
variate analysis. Significance was set at p 0.05.
Results: Seventy-nine patients had complete data. The
group was 79.5% male, had an average age of 74.5  8.8
years and an average AAA diameter of 5.59  0.9 cm.
Twenty four of 79 patients had a EndoSure reading which
signaled non-exclusion of the aortic sac. Of these, four hada CT-verified type I or III endoleak. Overall the sensitivity
was 0.90 and the specificity was 0.31 for exclusion of the
sac. The positive predictive value was 0.95 and the negative
predictive value was 0.16. Patients with false negatives for
sac exclusion were significantly younger than those who
had a type I or III endoleak (71.6 1.7 vs 79.5 2.7, p
0.05). Also, male patients were significantly higher in false
negatives than in true type I or III endoleaks (85% vs 25%,
p  0.01). No other variables were significantly different
between groups. If EndoSure had been used as the sole
diagnostic test, it would have triggered 20 unnecessary CT
scans.
Conclusions:CardioMEMSEndoSurehas ahigh sensitiv-
ity andpositivepredictive value fordetecting sac exclusion.How-
ever, its high negative predictive value may lead to unnecessary
tests. This tends to affect younger andmale patients more often.
Author Disclosures: W. M. Bogey: Nothing to disclose;
C. A. Durham: Nothing to disclose; C. I. Jones: Nothing
to disclose; M. M. McNally: Nothing to disclose; F. M.
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disclose; M. C. Stoner: Nothing to disclose.
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Intensive Statin Therapy Is Associated With a Decrease
in Adverse Events and Death Following Carotid Revas-
cularization
Catherine K. Chang1, Chetan P. Huded2, Philip P. Good-
ney1, Brian W. Nolan1, Daniel B. Walsh1, Richard J. Pow-
ell1. 1Vascular Surgery, Dartmouth Hitchcock Medical
Center, Lebanon, NH; 2Dartmouth Medical School,
Hanover, NH
Objectives: To determine whether high dose statin
therapy is associated with a reduction in major adverse
events when compared to low/moderate dose or no statin
therapy following carotid revascularization.
Methods: A retrospective review was performed of 872
consecutive carotid endarterectomy (CEA) and carotid artery
stenting (CAS) procedures in 804 patients between 1/2003
and 3/2009. Patient demographics, co-morbidities, and clin-
ical outcomes were collected. High dose statin therapy was
defined as atorvastatin, simvastatin, pravastatin, lovastatin, or
fluvastatin at 80 mg/day or rosuvastatin at 20 mg/day start-
ing before or at time of procedure. The composite primary
outcome measure was all-cause mortality, stroke, any reinter-
vention, and recurrent stenosis 70% at 5 years. Statistical
analysis utilized a multivariate logistic regression model.
Results: At time of carotid revascularization, 216 pa-
tients were on no statin, 548 on a low or moderate dose, and
108 on a high dose statin. Hypertension, diabetes, coronary
artery disease, peripheral arterial disease, and congestive heart
failure were all significantly more prevalent in the high dose
group.Highdose statinswere associatedwith a decrease in the
composite endpoint from 19% to 11% (p  0.05) compared
